Skip to main content
OpenTrials

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,775 public trials 831 recruiting studies
Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)

NCT05096091

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • National Institute for Biomedical Research/Institut National de Recherche Biomédicale (INRB) Gombe, Kinshasa City, Democratic Republic of the Congo
  • Partnership for Clinical Research in Guinea/Partenariat de Recherche Clinique en Guinée (PREGUI) Conakry, Guinea
  • National Institute of Health Research and Development (NIHRD), Ministry of Health, Republic of Jakarta - RSU Kabupaten Tangerang Tangerang, Indonesia
  • Partnership for Research in Vaccines and Infectious Diseases in Liberia (PREVAIL) - Duport Road Health Center Monrovia, Liberia
View Trial Details
Completed

The Late Presenter Treatment Optimisation Study

NCT03696160

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Institute of Tropical Medicine Antwerp, Belgium
  • CHU Saint-Pierre Brussels, Belgium
  • University Hospital Ghent Ghent, Belgium
  • Hopital Europeen Marseille Marseille, France
View all 53 locations
View Trial Details
Completed

TURN-COVID Biobank: The Dutch Cohort Study for the Evaluation of the Use of Neutralizing Monoclonal Antibodies and Other Antiviral Agents Against SARS-CoV-2

NCT05195060

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • Amsterdam University Medical centre - VUMC Amsterdam, North Holland, Netherlands
  • Amsterdam University Medical Centre Amsterdam, North Holland, Netherlands
  • Leiden universitair medisch centrum Leiden, Netherlands
  • Radboud Universitair Medisch Centrum Nijmegen, Netherlands
View Trial Details
Completed

To Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA

NCT06436911

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • University of Alberta Edmonton, Alberta, Canada
  • Centricity Research Burlington, Ontario, Canada
  • Centricity Research Toronto, Ontario, Canada
  • Centricity Research Toronto, Ontario, Canada
View Trial Details

Related conditions